Filing status
- Accounts due
- 30 November 2027
- Last accounts
- 28 February 2026
- Conf. stmt due
- 19 April 2027
- Last conf. stmt
- 5 April 2026
Crucible Therapeutics Limited
- Incorporated
- 27 February 2023 (3 years)
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Clifford HollowayJonathan Foley
- Owned by
- Argobio S.A.S.
- Accounts type
- Small
- Region
- Yorkshire
- Address
- The Innovation Centre217 PortobelloSheffieldS1 4DP
Officers 7 active
Officer details are public data from the Companies House register.
Holloway, Clifford
Director · Appointed 17 June 2026
British
Born March 1960 (66)
Macro, Samantha Jane, Dr
Secretary · Appointed 23 July 2025
Director · Appointed 17 October 2024
British
Born February 1990 (36)
Foley, Jonathan
Director · Appointed 21 September 2023
Canadian,British
Born June 1981 (45)
Livadiotis, Juliet Maria
Director · Appointed 21 September 2023
Cypriot
Born September 1980 (46)
Director · Appointed 21 September 2023
Also at Roji Limited · more companies
British
Born December 1953 (72)
Hautbergue, Guillaume Marcel Pierre, Professor
Director · Appointed 27 February 2023
French
Born October 1972 (54)
Officer history (2 former)
17 June 2026
Appointed Holloway, Clifford as Director
23 July 2025
Appointed Macro, Samantha Jane, Dr as Secretary
23 July 2025
Resigned Mcmaster, Ross Alexander as Secretary
17 October 2024
17 October 2024
10 October 2023
Appointed Mcmaster, Ross Alexander as Secretary
21 September 2023
Appointed Foley, Jonathan as Director
21 September 2023
Appointed Livadiotis, Juliet Maria as Director
21 September 2023
21 September 2023
27 February 2023
Appointed Hautbergue, Guillaume Marcel Pierre, Professor as Director
Ownership 2 active
People and entities with significant control, from the Companies House PSC register
Corporate entity · Notified 14 February 2024
Owns 25–50% of shares
Holds 25–50% of voting rights
Limited
Reg. no. 12982592
Argobio S.A.S.
Corporate entity · Notified 14 February 2024
Owns 25–50% of shares
Holds 25–50% of voting rights
Société Par Actions Simplifiée
Reg. no. 894233113
Former controllers (1)
21 September 2023
Ceased Guillaume Marcel Pierre Hautbergue — Right to appoint and remove directors
Group structure 17 shown
Ownership group derived from the Companies House PSC register
Adsilico Limited Owns 25–50% of shares
Amplisi Limited Owns 25–50% of shares
Auxetec Limited Owns 25–50% of shares
Cavero Quantum Limited Owns 25–50% of shares
Cavero Secure Limited Owns 75–100% of shares
Crucible Therapeutics Limited This company Owns 25–50% of shares
Cytotrait Limited Owns 25–50% of shares
Exciting Instruments Limited Owns 25–50% of shares
Floreon Technology Limited Owns 25–50% of shares
Ivfmicro Limited Owns 25–50% of shares
Mimetrik Solutions Limited Owns 25–50% of shares
Northern Gritstone Innovation Services Limited Owns 75–100% of shares
Northern Gritstone Investment Manager Limited Owns 75–100% of shares
Olo Robotics Ltd Owns 25–50% of shares
Optalysys Ltd Holds 25–50% of voting rights
Phovir Technologies Limited Owns 25–50% of shares
Filings
Recent filings only. See the full history on Companies House
| Date | Description | Made Up To | Pages | |
|---|---|---|---|---|
| 3 September 2026 | Accounts for a small company | 28 February 2026 | ||
| 7 November 2025 | Accounts for a small company | 28 February 2025 | 6 | |
| 14 August 2025 | Termination of appointment of a secretary | 1 | ||
| 14 August 2025 | Appointment of a secretary | 2 | ||
| 17 April 2025 | Statement of capital following an allotment of shares | 3 |
Some other companies at this address
Other companies in this industry
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →